Researchers from Finland have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a new study.
Researchers from Finland have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a new study.